Tapewire

NYSE · USD

WD

Walker & Dunlop, Inc.

Export transactions ↓
Tapewire entity
4737
SEC CIK
0001497770
Parsed reports
515

Last 12 months

Inside the activity.

4 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202640
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 04, 2021 Filed Jun 8, 2021 20:34 UTC
Lucas Richard MEVP & Gen Counsel & Secretary
GrantDividend Equivalent Rights · Derivative 30.19 $0.00 $0.00
Disclosure

SEC source: 0001104659-21-078269 · tm2119104-4_4seq1.xml · derivative · entry 1

Lucas Richard M · CIK 0001503845 · EVP & Gen Counsel & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 199.147

Underlying: Common Stock · 30.19 shares

Expires not disclosed

F1 · derivative.exercise_price: Each dividend equivalent right is the economic equivalent of one share of common stock of the Company.

F2 · derivative.exercise_date: The dividend equivalent rights accrued on restricted stock units held by the reporting person and will vest proportionately with the restricted stock units to which they relate.

F2 · derivative.expiration_date: The dividend equivalent rights accrued on restricted stock units held by the reporting person and will vest proportionately with the restricted stock units to which they relate.

Read SEC document
June 04, 2021 Filed Jun 8, 2021 20:33 UTC
Smith Howard W IIIDirector · President
GrantDividend Equivalent Rights · Derivative 33.311 $0.00 $0.00
Disclosure

SEC source: 0001104659-21-078267 · tm2119104-3_4seq1.xml · derivative · entry 1

Smith Howard W III · CIK 0001503844 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 212.152

Underlying: Common Stock · 33.311 shares

Expires not disclosed

F1 · derivative.exercise_price: Each dividend equivalent right is the economic equivalent of one share of common stock of the Company.

F2 · derivative.exercise_date: The dividend equivalent rights accrued on restricted stock units held by the reporting person and will vest proportionately with the restricted stock units to which they relate.

F2 · derivative.expiration_date: The dividend equivalent rights accrued on restricted stock units held by the reporting person and will vest proportionately with the restricted stock units to which they relate.

Read SEC document
June 04, 2021 Filed Jun 8, 2021 20:32 UTC OtherCommon Stock 6.316 $100.53 $634.97
Disclosure

SEC source: 0001104659-21-078266 · tm2119104-2_4seq1.xml · nonDerivative · entry 1

Bowers Alan J · CIK 0001503849 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,964.1644

Read SEC document
June 02, 2021 Filed Mar 17, 2022 21:02 UTC OtherCommon Stock 2.581 $100.54 $259.50
Disclosure

SEC source: 0001104659-22-035091 · tm229210-11_4seq1.xml · nonDerivative · entry 1

Warren Michael J. · CIK 0001698331 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 521.581

F1 · price: The reporting person's acquisition of shares of Common Stock on June 2, 2021 was matchable under Section 16(b) of the Exchange Act of 1934, to the extent of 2.581 shares, with the reporting person's disposition of 2,000 shares of Common Stock on February 18, 2021 at a weighted average price of $101.4674 per share. The reporting person has paid the Issuer $2.43, representing the full amount of the profit realized in connection with these transactions.

Read SEC document
May 06, 2021 Filed May 10, 2021 21:02 UTC GrantDeferred Stock Units · Derivative 1,141 $0.00 $0.00
Disclosure

SEC source: 0001104659-21-063972 · tm2115746-6_4seq1.xml · derivative · entry 2

SCHMALTZ DANA L · CIK 0001104397 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,141

Underlying: Common Stock · 1,141 shares

Expires not disclosed

F2 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of common stock of the Issuer.

F3 · derivative.exercise_date: The deferred stock units are fully vested and will be settled in shares of the Issuer's common stock either (i) on a date selected by the reporting person pursuant to the Issuer's Deferred Compensation Plan for Non-Employee Directors (the "Plan"), or (ii) as otherwise provided by the Plan.

F3 · derivative.expiration_date: The deferred stock units are fully vested and will be settled in shares of the Issuer's common stock either (i) on a date selected by the reporting person pursuant to the Issuer's Deferred Compensation Plan for Non-Employee Directors (the "Plan"), or (ii) as otherwise provided by the Plan.

Read SEC document
May 06, 2021 Filed May 10, 2021 21:02 UTC GrantCommon Stock 992 $0.00 $0.00
Disclosure

SEC source: 0001104659-21-063972 · tm2115746-6_4seq1.xml · nonDerivative · entry 1

SCHMALTZ DANA L · CIK 0001104397 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,395

F1 · shares: Represents shares of common stock granted to the reporting person, which are subject to the terms of the Walker & Dunlop, Inc. 2020 Equity Incentive Plan. The shares of restricted common stock vest on the one-year anniversary of the grant date.

Read SEC document
May 06, 2021 Filed May 10, 2021 21:03 UTC GrantDeferred Stock Units · Derivative 1,092 $0.00 $0.00
Disclosure

SEC source: 0001104659-21-063974 · tm2115746-7_4seq1.xml · derivative · entry 2

Warren Michael J. · CIK 0001698331 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,092

Underlying: Common Stock · 1,092 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of common stock of the Issuer.

F3 · derivative.exercise_date: The deferred stock units are fully vested and will be settled in shares of the Issuer's common stock either (i) on a date selected by the reporting person pursuant to the Plan, or (ii) as otherwise provided by the Plan.

F3 · derivative.expiration_date: The deferred stock units are fully vested and will be settled in shares of the Issuer's common stock either (i) on a date selected by the reporting person pursuant to the Plan, or (ii) as otherwise provided by the Plan.

Read SEC document
May 06, 2021 Filed May 10, 2021 21:03 UTC GrantDeferred Stock Units · Derivative 992 $0.00 $0.00
Disclosure

SEC source: 0001104659-21-063974 · tm2115746-7_4seq1.xml · derivative · entry 1

Warren Michael J. · CIK 0001698331 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 992

Underlying: Common Stock · 992 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of common stock of the Issuer.

F2 · derivative.exercise_date: The deferred stock units vest on the one-year anniversary of the grant date and will be settled in shares of the Issuer's common stock either (i) on a date selected by the reporting person pursuant to the Issuer's Deferred Compensation Plan for Non-Employee Directors (the "Plan"), or (ii) as otherwise provided by the Plan.

F2 · derivative.expiration_date: The deferred stock units vest on the one-year anniversary of the grant date and will be settled in shares of the Issuer's common stock either (i) on a date selected by the reporting person pursuant to the Issuer's Deferred Compensation Plan for Non-Employee Directors (the "Plan"), or (ii) as otherwise provided by the Plan.

Read SEC document
May 06, 2021 Filed May 10, 2021 21:02 UTC GrantDeferred Stock Units · Derivative 992 $0.00 $0.00
Disclosure

SEC source: 0001104659-21-063966 · tm2115746-5_4seq1.xml · derivative · entry 1

Malone Michael D · CIK 0001421021 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 992

Underlying: Common Stock · 992 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of common stock of the Issuer.

F2 · derivative.exercise_date: The deferred stock units vest on the one-year anniversary of the grant date and will be settled in shares of the Issuer's common stock either (i) on a date selected by the reporting person pursuant to the Issuer's Deferred Compensation Plan for Non-Employee Directors (the "Plan"), or (ii) as otherwise provided by the Plan.

F2 · derivative.expiration_date: The deferred stock units vest on the one-year anniversary of the grant date and will be settled in shares of the Issuer's common stock either (i) on a date selected by the reporting person pursuant to the Issuer's Deferred Compensation Plan for Non-Employee Directors (the "Plan"), or (ii) as otherwise provided by the Plan.

Read SEC document
May 06, 2021 Filed May 10, 2021 21:01 UTC
Levy EllenDirector
GrantDeferred Stock Units · Derivative 992 $0.00 $0.00
Disclosure

SEC source: 0001104659-21-063963 · tm2115746-3_4seq1.xml · derivative · entry 1

Levy Ellen · CIK 0001657271 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 992

Underlying: Common Stock · 992 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of common stock of the Issuer.

F2 · derivative.exercise_date: The deferred stock units vest on the one-year anniversary of the grant date and will be settled in shares of the Issuer's common stock either (i) on a date selected by the reporting person pursuant to the Issuer's Deferred Compensation Plan for Non-Employee Directors (the "Plan"), or (ii) as otherwise provided by the Plan.

F2 · derivative.expiration_date: The deferred stock units vest on the one-year anniversary of the grant date and will be settled in shares of the Issuer's common stock either (i) on a date selected by the reporting person pursuant to the Issuer's Deferred Compensation Plan for Non-Employee Directors (the "Plan"), or (ii) as otherwise provided by the Plan.

Read SEC document
May 06, 2021 Filed May 10, 2021 21:01 UTC GrantCommon Stock 992 $0.00 $0.00
Disclosure

SEC source: 0001104659-21-063964 · tm2115746-4_4seq1.xml · nonDerivative · entry 1

Rice E. John Jr · CIK 0001503875 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,001

F1 · shares: Represents shares of common stock granted to the reporting person, which are subject to the terms of the Walker & Dunlop, Inc. 2020 Equity Incentive Plan. The shares of restricted common stock vest on the one-year anniversary of the grant date.

Read SEC document
May 06, 2021 Filed May 10, 2021 21:00 UTC GrantDeferred Stock Units · Derivative 744 $0.00 $0.00
Disclosure

SEC source: 0001104659-21-063957 · tm2115746-1_4seq1.xml · derivative · entry 2

Bowers Alan J · CIK 0001503849 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 744

Underlying: Common Stock · 744 shares

Expires not disclosed

F2 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of common stock of the Issuer.

F3 · derivative.exercise_date: The deferred stock units are fully vested and will be settled in shares of the Issuer's common stock either (i) on a date selected by the reporting person pursuant to the Issuer's Deferred Compensation Plan for Non-Employee Directors (the "Plan"), or (ii) as otherwise provided by the Plan.

F3 · derivative.expiration_date: The deferred stock units are fully vested and will be settled in shares of the Issuer's common stock either (i) on a date selected by the reporting person pursuant to the Issuer's Deferred Compensation Plan for Non-Employee Directors (the "Plan"), or (ii) as otherwise provided by the Plan.

Read SEC document
May 06, 2021 Filed May 10, 2021 21:00 UTC GrantCommon Stock 992 $0.00 $0.00
Disclosure

SEC source: 0001104659-21-063957 · tm2115746-1_4seq1.xml · nonDerivative · entry 1

Bowers Alan J · CIK 0001503849 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,957.8484

F1 · shares: Represents shares of common stock granted to the reporting person, which are subject to the terms of the Walker & Dunlop, Inc. 2020 Equity Incentive Plan. The shares of restricted common stock vest on the one-year anniversary of the grant date.

Read SEC document
May 06, 2021 Filed May 10, 2021 21:00 UTC
Wells DonnaDirector
GrantDeferred Stock Units · Derivative 992 $0.00 $0.00
Disclosure

SEC source: 0001104659-21-063959 · tm2115746-2_4seq1.xml · derivative · entry 1

Wells Donna · CIK 0001613921 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 992

Underlying: Common Stock · 992 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of common stock of the Issuer.

F2 · derivative.exercise_date: The deferred stock units vest on the one-year anniversary of the grant date and will be settled in shares of the Issuer's common stock either (i) on a date selected by the reporting person pursuant to the Issuer's Deferred Compensation Plan for Non-Employee Directors (the "Plan"), or (ii) as otherwise provided by the Plan.

F2 · derivative.expiration_date: The deferred stock units vest on the one-year anniversary of the grant date and will be settled in shares of the Issuer's common stock either (i) on a date selected by the reporting person pursuant to the Issuer's Deferred Compensation Plan for Non-Employee Directors (the "Plan"), or (ii) as otherwise provided by the Plan.

Read SEC document
May 03, 2021 Filed May 5, 2021 21:00 UTC
Smith Howard W IIIDirector · President
Exercise / conversionStock Option (right to buy) · Derivative 15,000 $0.00 Strike: $17.05 $0.00
Disclosure

SEC source: 0001104659-21-061798 · tm2115238-1_4seq1.xml · derivative · entry 9

Smith Howard W III · CIK 0001503844 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,513

Underlying: Common Stock · 15,000 shares

Expires 2024-02-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 03, 2021 Filed May 5, 2021 21:00 UTC
Smith Howard W IIIDirector · President
SaleCommon Stock 8,012 $112.64 $902,439.63
Disclosure

SEC source: 0001104659-21-061798 · tm2115238-1_4seq1.xml · nonDerivative · entry 2

Smith Howard W III · CIK 0001503844 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 148,743.772

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2020.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.08 to $113.04. The reporting person undertakes to provide Walker & Dunlop, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 03, 2021 Filed May 5, 2021 21:00 UTC
Smith Howard W IIIDirector · President
Exercise / conversionCommon Stock 15,000 $17.05 $255,750.00
Disclosure

SEC source: 0001104659-21-061798 · tm2115238-1_4seq1.xml · nonDerivative · entry 1

Smith Howard W III · CIK 0001503844 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 156,755.772

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 05, 2021 Filed Apr 6, 2021 21:01 UTC
Smith Howard W IIIDirector · President
Exercise / conversionStock Option (right to buy) · Derivative 15,000 $0.00 Strike: $17.05 $0.00
Disclosure

SEC source: 0001104659-21-047157 · tm2112315-1_4seq1.xml · derivative · entry 9

Smith Howard W III · CIK 0001503844 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,513

Underlying: Common Stock · 15,000 shares

Expires 2024-02-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 05, 2021 Filed Apr 6, 2021 21:01 UTC
Smith Howard W IIIDirector · President
SaleCommon Stock 8,087 $105.96 $856,902.56
Disclosure

SEC source: 0001104659-21-047157 · tm2112315-1_4seq1.xml · nonDerivative · entry 2

Smith Howard W III · CIK 0001503844 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 141,755.772

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2020.

F2 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $105.935 to $106.50. The reporting person undertakes to provide Walker & Dunlop, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote

Read SEC document
April 05, 2021 Filed Apr 6, 2021 21:01 UTC
Smith Howard W IIIDirector · President
Exercise / conversionCommon Stock 15,000 $17.05 $255,750.00
Disclosure

SEC source: 0001104659-21-047157 · tm2112315-1_4seq1.xml · nonDerivative · entry 1

Smith Howard W III · CIK 0001503844 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 149,842.772

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 31, 2021 Filed Apr 2, 2021 21:00 UTC
Walker William MDirector · Chairman & CEO
OtherCommon Stock 1,510,244 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-21-046141 · tm217076-17_4seq1.xml · nonDerivative · entry 1

Walker William M · CIK 0001503841 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Walker Family Holdings, LLC

Disclosed balance after: 1,510,244

F1 · kind: Reflects the transfer of LLC interests in Walker Family Holdings, LLC to two trusts for the benefit of the Reporting Person's family members in an estate planning transaction. As consideration for the transfer, the trusts issued promissory notes to the Reporting Person and the Reporting Person's spouse. The promissory notes had an aggregate initial estimated principal amount equal to $57,380,752. The Reporting Person is the sole managing member of Walker Family Holdings, LLC and, following the transaction reported herein, continues to exercise voting and dispositive power over the shares of Common Stock held by Walker Family Holdings, LLC. No shares of the Issuer's Common Stock were sold or transferred as a result of this transaction.

F1 · shares: Reflects the transfer of LLC interests in Walker Family Holdings, LLC to two trusts for the benefit of the Reporting Person's family members in an estate planning transaction. As consideration for the transfer, the trusts issued promissory notes to the Reporting Person and the Reporting Person's spouse. The promissory notes had an aggregate initial estimated principal amount equal to $57,380,752. The Reporting Person is the sole managing member of Walker Family Holdings, LLC and, following the transaction reported herein, continues to exercise voting and dispositive power over the shares of Common Stock held by Walker Family Holdings, LLC. No shares of the Issuer's Common Stock were sold or transferred as a result of this transaction.

F1 · price: Reflects the transfer of LLC interests in Walker Family Holdings, LLC to two trusts for the benefit of the Reporting Person's family members in an estate planning transaction. As consideration for the transfer, the trusts issued promissory notes to the Reporting Person and the Reporting Person's spouse. The promissory notes had an aggregate initial estimated principal amount equal to $57,380,752. The Reporting Person is the sole managing member of Walker Family Holdings, LLC and, following the transaction reported herein, continues to exercise voting and dispositive power over the shares of Common Stock held by Walker Family Holdings, LLC. No shares of the Issuer's Common Stock were sold or transferred as a result of this transaction.

F2 · balance_after: Reflects the transfer of Common Stock from Mr. Walker to Walker Family Holdings, LLC for no consideration. The previous Form 4 filed by the Reporting Person overstated the number of shares beneficially owned by the Reporting Person by 13,757 shares of Common Stock. The amount reported herein has been corrected.

Read SEC document
March 18, 2021 Filed Mar 19, 2021 21:00 UTC SaleCommon Stock 2,200 $112.16 $246,762.78
Disclosure

SEC source: 0001104659-21-039165 · tm217076-15_4seq1.xml · nonDerivative · entry 1

Rice E. John Jr · CIK 0001503875 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,009

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.88 to $112.73. The reporting person undertakes to provide Walker & Dunlop, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
March 17, 2021 Filed Mar 19, 2021 21:01 UTC
THEOBALD STEPHEN PEVP & Chief Financial Officer
SaleCommon Stock 1,035 $111.11 $114,999.37
Disclosure

SEC source: 0001104659-21-039170 · tm217076-16_4.xml · nonDerivative · entry 5

THEOBALD STEPHEN P · CIK 0001507723 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,004.37

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.00 to $111.50. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
March 17, 2021 Filed Mar 19, 2021 21:01 UTC
THEOBALD STEPHEN PEVP & Chief Financial Officer
SaleCommon Stock 3,003 $110.72 $332,494.86
Disclosure

SEC source: 0001104659-21-039170 · tm217076-16_4.xml · nonDerivative · entry 4

THEOBALD STEPHEN P · CIK 0001507723 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,039.37

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.99 to $110.98. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
March 17, 2021 Filed Mar 19, 2021 21:01 UTC
THEOBALD STEPHEN PEVP & Chief Financial Officer
SaleCommon Stock 2,000 $109.30 $218,595.00
Disclosure

SEC source: 0001104659-21-039170 · tm217076-16_4.xml · nonDerivative · entry 3

THEOBALD STEPHEN P · CIK 0001507723 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,042.37

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.90 to $109.90. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
March 17, 2021 Filed Mar 19, 2021 21:01 UTC
THEOBALD STEPHEN PEVP & Chief Financial Officer
SaleCommon Stock 1,812 $108.37 $196,360.46
Disclosure

SEC source: 0001104659-21-039170 · tm217076-16_4.xml · nonDerivative · entry 2

THEOBALD STEPHEN P · CIK 0001507723 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,042.37

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.88 to $108.82. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
March 17, 2021 Filed Mar 19, 2021 21:01 UTC
THEOBALD STEPHEN PEVP & Chief Financial Officer
SaleCommon Stock 2,150 $107.13 $230,329.07
Disclosure

SEC source: 0001104659-21-039170 · tm217076-16_4.xml · nonDerivative · entry 1

THEOBALD STEPHEN P · CIK 0001507723 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,854.37

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.62 to $107.58. The reporting person undertakes to provide Walker & Dunlop, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
March 15, 2021 Filed Mar 17, 2021 21:01 UTC
Lucas Richard MEVP & Gen Counsel & Secretary
Exercise / conversionDividend Equivalent Rights · Derivative 179.167 $0.00 $0.00
Disclosure

SEC source: 0001104659-21-037773 · tm217076-14_4seq1.xml · derivative · entry 5

Lucas Richard M · CIK 0001503845 · EVP & Gen Counsel & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 168.957

Underlying: Common Stock · 179.167 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: The dividend equivalent rights accrued on restricted stock units held by the reporting person and vest proportionately with the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of common stock of the Issuer.

F5 · derivative.exercise_date: The dividend equivalent rights accrued on restricted stock units held by the reporting person and vest proportionately with the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of common stock of the Issuer.

F5 · derivative.expiration_date: The dividend equivalent rights accrued on restricted stock units held by the reporting person and vest proportionately with the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of common stock of the Issuer.

Read SEC document
March 15, 2021 Filed Mar 17, 2021 21:01 UTC
Lucas Richard MEVP & Gen Counsel & Secretary
Exercise / conversionRestricted Stock Units · Derivative 2,471 $0.00 $0.00
Disclosure

SEC source: 0001104659-21-037773 · tm217076-14_4seq1.xml · derivative · entry 4

Lucas Richard M · CIK 0001503845 · EVP & Gen Counsel & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,471 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of common stock of the Issuer.

F4 · derivative.exercise_date: The restricted stock units were settled in shares of the Issuer's common stock on March 15, 2021.

F4 · derivative.expiration_date: The restricted stock units were settled in shares of the Issuer's common stock on March 15, 2021.

Read SEC document
March 15, 2021 Filed Mar 17, 2021 21:01 UTC
Lucas Richard MEVP & Gen Counsel & Secretary
Exercise / conversionDeferred Stock Units · Derivative 4,943 $0.00 $0.00
Disclosure

SEC source: 0001104659-21-037773 · tm217076-14_4seq1.xml · derivative · entry 3

Lucas Richard M · CIK 0001503845 · EVP & Gen Counsel & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,943 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of common stock of the Issuer.

F2 · derivative.exercise_date: The deferred stock units are fully vested and were settled in shares of the Issuer's common stock on March 15, 2021 pursuant to the Walker & Dunlop, Inc. Management Deferred Stock Unit Purchase Plan.

F2 · derivative.expiration_date: The deferred stock units are fully vested and were settled in shares of the Issuer's common stock on March 15, 2021 pursuant to the Walker & Dunlop, Inc. Management Deferred Stock Unit Purchase Plan.

Read SEC document
March 15, 2021 Filed Mar 17, 2021 21:01 UTC
Lucas Richard MEVP & Gen Counsel & Secretary
Tax withholdingCommon Stock 3,310 $112.19 $371,348.90
Disclosure

SEC source: 0001104659-21-037773 · tm217076-14_4seq1.xml · nonDerivative · entry 2

Lucas Richard M · CIK 0001503845 · EVP & Gen Counsel & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 123,281.352

Read SEC document
March 15, 2021 Filed Mar 17, 2021 21:01 UTC
Lucas Richard MEVP & Gen Counsel & Secretary
Exercise / conversionCommon Stock 7,593.167 $0.00 $0.00
Disclosure

SEC source: 0001104659-21-037773 · tm217076-14_4seq1.xml · nonDerivative · entry 1

Lucas Richard M · CIK 0001503845 · EVP & Gen Counsel & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 126,591.352

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 15, 2021 Filed Mar 17, 2021 21:00 UTC
Smith Howard W IIIDirector · President
Exercise / conversionDividend Equivalent Rights · Derivative 358.402 $0.00 $0.00
Disclosure

SEC source: 0001104659-21-037769 · tm217076-13_4seq1.xml · derivative · entry 11

Smith Howard W III · CIK 0001503844 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 178.841

Underlying: Common Stock · 358.402 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: The dividend equivalent rights accrued on restricted stock units held by the reporting person and vest proportionately with the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of common stock of the Issuer.

F5 · derivative.exercise_date: The dividend equivalent rights accrued on restricted stock units held by the reporting person and vest proportionately with the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of common stock of the Issuer.

F5 · derivative.expiration_date: The dividend equivalent rights accrued on restricted stock units held by the reporting person and vest proportionately with the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of common stock of the Issuer.

Read SEC document
March 15, 2021 Filed Mar 17, 2021 21:00 UTC
Smith Howard W IIIDirector · President
Exercise / conversionRestricted Stock Units · Derivative 4,943 $0.00 $0.00
Disclosure

SEC source: 0001104659-21-037769 · tm217076-13_4seq1.xml · derivative · entry 10

Smith Howard W III · CIK 0001503844 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,943 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of common stock of the Issuer.

F4 · derivative.exercise_date: The restricted stock units were settled in shares of the Issuer's common stock on March 15, 2021.

F4 · derivative.expiration_date: The restricted stock units were settled in shares of the Issuer's common stock on March 15, 2021.

Read SEC document
March 15, 2021 Filed Mar 17, 2021 21:00 UTC
Smith Howard W IIIDirector · President
Exercise / conversionDeferred Stock Units · Derivative 11,586 $0.00 $0.00
Disclosure

SEC source: 0001104659-21-037769 · tm217076-13_4seq1.xml · derivative · entry 9

Smith Howard W III · CIK 0001503844 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 11,586 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of common stock of the Issuer.

F2 · derivative.exercise_date: The deferred stock units are fully vested and were settled in shares of the Issuer's common stock on March 15, 2021 pursuant to the Walker & Dunlop, Inc. Management Deferred Stock Unit Purchase Plan.

F2 · derivative.expiration_date: The deferred stock units are fully vested and were settled in shares of the Issuer's common stock on March 15, 2021 pursuant to the Walker & Dunlop, Inc. Management Deferred Stock Unit Purchase Plan.

Read SEC document
March 15, 2021 Filed Mar 17, 2021 21:00 UTC
Smith Howard W IIIDirector · President
Tax withholdingCommon Stock 7,345 $112.19 $824,035.55
Disclosure

SEC source: 0001104659-21-037769 · tm217076-13_4seq1.xml · nonDerivative · entry 2

Smith Howard W III · CIK 0001503844 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 134,842.772

Read SEC document
March 15, 2021 Filed Mar 17, 2021 21:00 UTC
Smith Howard W IIIDirector · President
Exercise / conversionCommon Stock 16,887.402 $0.00 $0.00
Disclosure

SEC source: 0001104659-21-037769 · tm217076-13_4seq1.xml · nonDerivative · entry 1

Smith Howard W III · CIK 0001503844 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 142,187.772

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 12, 2021 Filed Mar 15, 2021 21:04 UTC OtherCommon Stock 14.6523 $108.33 $1,587.27
Disclosure

SEC source: 0001104659-21-036357 · tm219757-6_4seq1.xml · nonDerivative · entry 2

Bowers Alan J · CIK 0001503849 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,965.8484

Read SEC document
March 11, 2021 Filed Mar 15, 2021 21:01 UTC
Pryor Paula A.EVP & Chief HR Officer
GrantDividend Equivalent Rights · Derivative 21.529 $0.00 $0.00
Disclosure

SEC source: 0001104659-21-036347 · tm219757-1_4seq1.xml · derivative · entry 1

Pryor Paula A. · CIK 0001811383 · EVP & Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 115.551

Underlying: Common Stock · 21.529 shares

Expires not disclosed

F1 · derivative.exercise_price: Each dividend equivalent right is the economic equivalent of one share of common stock of the Company.

F2 · derivative.exercise_date: The dividend equivalent rights accrued on restricted stock units held by the reporting person and will vest proportionately with the restricted stock units to which they relate.

F2 · derivative.expiration_date: The dividend equivalent rights accrued on restricted stock units held by the reporting person and will vest proportionately with the restricted stock units to which they relate.

Read SEC document
March 11, 2021 Filed Mar 15, 2021 21:04 UTC OtherCommon Stock 6.327 $99.85 $631.78
Disclosure

SEC source: 0001104659-21-036357 · tm219757-6_4seq1.xml · nonDerivative · entry 1

Bowers Alan J · CIK 0001503849 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,951.1961

Read SEC document
March 11, 2021 Filed Mar 15, 2021 21:03 UTC
Smith Howard W IIIDirector · President
GrantDividend Equivalent Rights · Derivative 55.07 $0.00 $0.00
Disclosure

SEC source: 0001104659-21-036356 · tm219757-5_4seq1.xml · derivative · entry 1

Smith Howard W III · CIK 0001503844 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 537.2431

Underlying: Common Stock · 55.07 shares

Expires not disclosed

F1 · derivative.exercise_price: Each dividend equivalent right is the economic equivalent of one share of common stock of the Company.

F2 · derivative.exercise_date: The dividend equivalent rights accrued on restricted stock units held by the reporting person and will vest proportionately with the restricted stock units to which they relate.

F2 · derivative.expiration_date: The dividend equivalent rights accrued on restricted stock units held by the reporting person and will vest proportionately with the restricted stock units to which they relate.

Read SEC document
March 11, 2021 Filed Mar 15, 2021 21:03 UTC
Lucas Richard MEVP & Gen Counsel & Secretary
GrantDividend Equivalent Rights · Derivative 40.044 $0.00 $0.00
Disclosure

SEC source: 0001104659-21-036353 · tm219757-4_4seq1.xml · derivative · entry 1

Lucas Richard M · CIK 0001503845 · EVP & Gen Counsel & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 348.1236

Underlying: Common Stock · 40.044 shares

Expires not disclosed

F1 · derivative.exercise_price: Each dividend equivalent right is the economic equivalent of one share of common stock of the Company.

F2 · derivative.exercise_date: The dividend equivalent rights accrued on restricted stock units held by the reporting person and will vest proportionately with the restricted stock units to which they relate.

F2 · derivative.expiration_date: The dividend equivalent rights accrued on restricted stock units held by the reporting person and will vest proportionately with the restricted stock units to which they relate.

Read SEC document
March 11, 2021 Filed Mar 15, 2021 21:02 UTC
Walker William MDirector · Chairman & CEO
GrantDividend Equivalent Rights · Derivative 41.884 $0.00 $0.00
Disclosure

SEC source: 0001104659-21-036352 · tm219757-3_4seq1.xml · derivative · entry 1

Walker William M · CIK 0001503841 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 271.1174

Underlying: Common Stock · 41.884 shares

Expires not disclosed

F1 · derivative.exercise_price: Each dividend equivalent right is the economic equivalent of one share of common stock of the Company.

F2 · derivative.exercise_date: The dividend equivalent rights accrued on restricted stock units held by the reporting person and will vest proportionately with the restricted stock units to which they relate.

F2 · derivative.expiration_date: The dividend equivalent rights accrued on restricted stock units held by the reporting person and will vest proportionately with the restricted stock units to which they relate.

Read SEC document
March 11, 2021 Filed Mar 15, 2021 21:02 UTC
THEOBALD STEPHEN PEVP & Chief Financial Officer
GrantDividend Equivalent Rights · Derivative 51.429 $0.00 $0.00
Disclosure

SEC source: 0001104659-21-036349 · tm219757-2_4seq1.xml · derivative · entry 1

THEOBALD STEPHEN P · CIK 0001507723 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 593.902

Underlying: Common Stock · 51.429 shares

Expires not disclosed

F1 · derivative.exercise_price: Each dividend equivalent right is the economic equivalent of one share of common stock of the Company.

F2 · derivative.exercise_date: The dividend equivalent rights accrued on restricted stock units held by the reporting person and will vest proportionately with the restricted stock units to which they relate.

F2 · derivative.expiration_date: The dividend equivalent rights accrued on restricted stock units held by the reporting person and will vest proportionately with the restricted stock units to which they relate.

Read SEC document
March 03, 2021 Filed Mar 5, 2021 21:32 UTC
Wells DonnaDirector
GrantDeferred Stock Units · Derivative 169 $0.00 $0.00
Disclosure

SEC source: 0001104659-21-032771 · tm217076-12_4seq1.xml · derivative · entry 1

Wells Donna · CIK 0001613921 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 169

Underlying: Common Stock · 169 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of common stock of the Issuer.

F2 · derivative.exercise_date: The deferred stock units will vest on May 14, 2021 and will be settled in shares of the Issuer's common stock either (i) on a date selected by the reporting person pursuant to the Issuer's Management Deferred Stock Unit Purchase Plan, as amended (the "Plan"), or (ii) as otherwise provided by the Plan.

F2 · derivative.expiration_date: The deferred stock units will vest on May 14, 2021 and will be settled in shares of the Issuer's common stock either (i) on a date selected by the reporting person pursuant to the Issuer's Management Deferred Stock Unit Purchase Plan, as amended (the "Plan"), or (ii) as otherwise provided by the Plan.

Read SEC document
March 01, 2021 Filed Mar 2, 2021 23:23 UTC
Smith Howard W IIIDirector · President
Exercise / conversionStock Option (right to buy) · Derivative 15,000 $0.00 Strike: $17.05 $0.00
Disclosure

SEC source: 0001104659-21-030881 · tm217076-10_4seq1.xml · derivative · entry 9

Smith Howard W III · CIK 0001503844 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,513

Underlying: Common Stock · 15,000 shares

Expires 2024-02-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 01, 2021 Filed Mar 2, 2021 23:23 UTC
Smith Howard W IIIDirector · President
SaleCommon Stock 8,150 $101.64 $828,366.00
Disclosure

SEC source: 0001104659-21-030881 · tm217076-10_4seq1.xml · nonDerivative · entry 2

Smith Howard W III · CIK 0001503844 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 125,300.37

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2020.

Read SEC document
March 01, 2021 Filed Mar 2, 2021 23:23 UTC
Smith Howard W IIIDirector · President
Exercise / conversionCommon Stock 15,000 $17.05 $255,750.00
Disclosure

SEC source: 0001104659-21-030881 · tm217076-10_4seq1.xml · nonDerivative · entry 1

Smith Howard W III · CIK 0001503844 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 133,450.37

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 22, 2021 Filed Feb 24, 2021 22:01 UTC
Pryor Paula A.EVP & Chief HR Officer
SaleCommon Stock 1,946 $105.81 $205,897.89
Disclosure

SEC source: 0001104659-21-027548 · tm217076-9_4seq1.xml · nonDerivative · entry 4

Pryor Paula A. · CIK 0001811383 · EVP & Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,786.691

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2020.

F5 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $105.57 to $106.20. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 22, 2021 Filed Feb 24, 2021 22:01 UTC
Pryor Paula A.EVP & Chief HR Officer
SaleCommon Stock 1,133 $104.79 $118,732.40
Disclosure

SEC source: 0001104659-21-027548 · tm217076-9_4seq1.xml · nonDerivative · entry 3

Pryor Paula A. · CIK 0001811383 · EVP & Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,732.691

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2020.

F4 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $104.40 to $105.31. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.